SCHEMBL22825599

SCHEMBL22825599

Cc1ccc(N2c3ccccc3C3(c4ccccc4-c4ccccc43)c3cc(C=C4C(=O)c5cc(Cl)c(Cl)cc5C4=O)ccc32)c(C)c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LCK P06239 2/20 0.38
S1PR1 P21453 2/20 0.37
S1PR3 Q99500 2/20 0.37
MAPT P10636 6/20 0.35
L3MBTL1 Q9Y468 5/20 0.35
CYP1A2 P05177 1/20 0.35
CYP2D6 P10635 1/20 0.35
CYP2C9 P11712 1/20 0.35
CYP2C19 P33261 1/20 0.35
TDP1 Q9NUW8 1/20 0.35
SMN1; SMN2 Q16637 3/20 0.34
LMNA P02545 2/20 0.34
KMT2A Q03164 5/20 0.33
MEN1 O00255 4/20 0.33
ALDH1A1 P00352 4/20 0.33
CSNK2A2 P19784 1/20 0.33
CSNK2B P67870 1/20 0.33
CSNK2A1 P68400 1/20 0.33
CSNK2A3 Q8NEV1 1/20 0.33
ALPL P05186 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25850032 0.83 CSNK2A2 (0.40) LCKMAPTL3MBTL1TDP1SMN1; SMN2
SCHEMBL22825590 0.83 LCK (0.34) LCKMAPTL3MBTL1TDP1SMN1; SMN2
SCHEMBL22826008 0.82 DHODH (0.35) LCKMAPTL3MBTL1SMN1; SMN2KMT2A
SCHEMBL22825591 0.82 PGR (0.35) S1PR1S1PR3MAPTTDP1SMN1; SMN2
SCHEMBL22825598 0.82 MDM4 (0.33) LCKMAPTL3MBTL1TDP1SMN1; SMN2
SCHEMBL22826060 0.78 KMT2A (0.37) LCKMAPTL3MBTL1TDP1SMN1; SMN2
SCHEMBL22825597 0.77 MEN1 (0.38) LCKMAPTSMN1; SMN2KMT2AMEN1
SCHEMBL22826497 0.77 LCK (0.36) LCKMAPTL3MBTL1TDP1SMN1; SMN2
SCHEMBL22826498 0.77 POLB (0.40) LCKMAPTL3MBTL1TDP1SMN1; SMN2
SCHEMBL16357161 0.76 LCK (0.41) LCKMAPTL3MBTL1TDP1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200403163-A1 PHOTOELECTRIC CONVERSION ELEMENT, IMAGING ELEMENT, OPTICAL SENSOR, AND COMPOUND FUJIFILM CORPORATION (JP) 2020-12-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200403163-A1 PHOTOELECTRIC CONVERSION ELEMENT, IMAGING ELEMENT, OPTICAL SENSOR, AND COMPOUND CRY1, CRY2, PIEZO1 LCK 4051/4885S1PR1 3961/4885S1PR3 4033/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.